Hagleitner, Melanie M <br/><br/>
Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts.  [electronic resource] 

 -  PloS one  2014 
 - e115869 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0115869  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--adverse effects<br/>Bone Neoplasms--drug therapy<br/>Catechol O-Methyltransferase--genetics<br/>Child<br/>Child, Preschool<br/>Cisplatin--adverse effects<br/>Female<br/>Genotype<br/>Hearing Loss--chemically induced<br/>Humans<br/>Male<br/>Methyltransferases--genetics<br/>Netherlands<br/>Osteosarcoma--drug therapy<br/>Polymorphism, Single Nucleotide<br/>Spain<br/>Young Adult